Serveur d'exploration Tocilizumab - Curation (PubMed)

Index « Auteurs » - entrée « Inger Byrjalsen »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Ingebj Rg Seljeflot < Inger Byrjalsen < Inger Jorid Berg  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
000771 (????) Natasja St Hr Gudmann [Danemark] ; Peter Junker [Danemark] ; Pernille Juhl [Danemark] ; Christian Schneider Thudium [Danemark] ; Anne Sofie Siebuhr [Danemark] ; Inger Byrjalsen [Danemark] ; Morten Asser Karsdal [Danemark] ; Anne Christine Bay-Jensen [Danemark]Type IV collagen metabolism is associated with disease activity, radiographic progression and response to tocilizumab in rheumatoid arthritis.
000A44 (????) Anne Sofie Siebuhr [Danemark] ; Cecilie F. Kjelgaard-Petersen [Danemark] ; Shu Sun [Danemark] ; Inger Byrjalsen [Danemark] ; Claus Christiansen [Danemark] ; Morten Asser Karsdal [Danemark] ; Anne-Christine Bay-Jensen [Danemark]Suppression of active, but not total MMP-3, is associated with treatment response in a phase III clinical study of rheumatoid arthritis.
000F64 (2016) Anne C. Bay-Jensen [Danemark] ; Adam Platt [Royaume-Uni] ; Anne Sofie Siebuhr [Danemark] ; Claus Christiansen [Danemark] ; Inger Byrjalsen [Danemark] ; Morten A. Karsdal [Danemark]Early changes in blood-based joint tissue destruction biomarkers are predictive of response to tocilizumab in the LITHE study.
001349 (2014) Anne C. Bay-Jensen [Royaume-Uni] ; Inger Byrjalsen ; Anne Sofie Siebuhr ; Claus Christiansen ; Adam Platt ; Morten A. KarsdalSerological biomarkers of joint tissue turnover predict tocilizumab response at baseline.
001618 (2013) Anne Sofie Siebuhr ; Anne C. Bay-Jensen ; Diana J. Leeming ; Adam Plat ; Inger Byrjalsen ; Claus Christiansen ; Désirée Van De Heijde ; Morten A. KarsdalSerological identification of fast progressors of structural damage with rheumatoid arthritis.
001620 (2014) Anne C. Bay-Jensen [Danemark] ; Adam Platt [Royaume-Uni] ; Inger Byrjalsen [Danemark] ; Philippe Vergnoud [France] ; Claus Christiansen [Danemark] ; Morten A. Karsdal [Danemark]Effect of tocilizumab combined with methotrexate on circulating biomarkers of synovium, cartilage, and bone in the LITHE study.
001899 (2012) Morten A. Karsdal [Danemark] ; Georg Schett ; Paul Emery ; Olivier Harari ; Inger Byrjalsen ; Andy Kenwright ; Anne C. Bay-Jensen ; Adam PlattIL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522).

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i -k "Inger Byrjalsen" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i  \
                -Sk "Inger Byrjalsen" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    Author.i
   |clé=    Inger Byrjalsen
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021